CCI vs FOLD · P/E 40, rev $6.57B vs rev $528.3M
Crown Castle (CCI) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the CCI and FOLD stock pages for the full models.
Not investment advice.